(Total Views: 648)
Posted On: 05/11/2017 6:01:25 PM
Post# of 72446
Did you also catch the trending article link on the site when reading the CTIX artical? $790M dollar licencing deal for a PHASE 1 drug candidate!!
So CTIX with a successful phase 2a and a seemingly successful phase 2b coming right down the pipe should be looking to command some serious coin. I realize that the two drugs are not apples to apples; this other drug is a topical application and they are attacking the problem from two different MOA's. However, with P being orally administered it could work worse than a topical and I would put money it is a more desirable drug. I think we may be seeing some big dollars eventually on the table for P.
https://psoriasisnewstoday.com/2017/01/05/pur...t-ast-005/
So CTIX with a successful phase 2a and a seemingly successful phase 2b coming right down the pipe should be looking to command some serious coin. I realize that the two drugs are not apples to apples; this other drug is a topical application and they are attacking the problem from two different MOA's. However, with P being orally administered it could work worse than a topical and I would put money it is a more desirable drug. I think we may be seeing some big dollars eventually on the table for P.
https://psoriasisnewstoday.com/2017/01/05/pur...t-ast-005/
(0)
(0)
